Effects of E-cigarette E-liquid components on bronchial epithelial cells: Demonstration of dysfunctional efferocytosis

Respirology

Volumn 25, Issue 6, 2020, Pages 620-628

  Ween, Miranda P ^a,b   Hamon, Rhys ^a,b   Macowan, Matthew G ^a,b   Thredgold, Leigh ^b   Reynolds, Paul R ^a,b   Hodge, Sandra J ^b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

airways; apoptosis; cytokines; E cigarettes; efferocytosis; macrophages

Indexed keywords

ANNEXIN; CD36 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCEROL; HERMES ANTIGEN; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NICOTINE; PATTERN RECOGNITION RECEPTOR; PROPYLENE GLYCOL; TUMOR NECROSIS FACTOR; CD36 PROTEIN, HUMAN; CD44 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; CXCL10 PROTEIN, HUMAN; HYALURONIC ACID BINDING PROTEIN; IL6 PROTEIN, HUMAN; MAPKAP1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TNF PROTEIN, HUMAN;

AIRWAY CELL; APOPTOSIS; APPLE; ARTICLE; BACTERIAL CELL; CELL DEATH; CELL MEDIATED CYTOTOXICITY; CELL SURFACE; CELL VIABILITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA MICROARRAY; EFFEROCYTOSIS; FLAVOR; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC VARIABILITY; HBEC CELL LINE (BRONCHIAL EPITHELIUM); HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN SECRETION; BIOSYNTHESIS; BRONCHUS; CELL LINE; CELL SURVIVAL; DRUG EFFECT; ELECTRONIC CIGARETTE; EPITHELIUM CELL; IMMUNOLOGY; METABOLISM; NECROSIS; PATHOPHYSIOLOGY; RESPIRATORY MUCOSA; TOBACCO;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; BRONCHI; CD36 ANTIGENS; CELL LINE; CELL SURVIVAL; CHEMOKINE CXCL10; ELECTRONIC NICOTINE DELIVERY SYSTEMS; EPITHELIAL CELLS; GLYCEROL; HUMANS; HYALURONAN RECEPTORS; INTERLEUKIN-6; MACROPHAGES; NECROSIS; NICOTINE; PHAGOCYTOSIS; PROPYLENE GLYCOL; RECEPTORS, CELL SURFACE; RESPIRATORY MUCOSA; TOBACCO PRODUCTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85073823113     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.13696     Document Type: Article

References (69)

1. Ween MP, Whittall JJ, Hamon R, Reynolds PN, Hodge SJ. Phagocytosis and inflammation: exploring the effects of the components of E-cigarette vapor on macrophages. Physiol. Rep. 2017; 5: pii: e13370.
2. Walsberger S, Havill M. NSW community behaviours, beliefs & attitudes towards E-cigarettes: results of an online survey. Cancer Council NSW, 2015.
3. Schoenborn CA, Gindi RM. Electronic cigarette use among adults: United States, 2014. NCHS Data Brief 2015; 217: 1–8.
4. Singh T, Kennedy S, Marynak K, Persoskie A, Melstrom P, King BA. Characteristics of electronic cigarette use among middle and high school students – United States, 2015. MMWR Morb. Mortal. Wkly Rep. 2016; 65: 1425–9.
5. Wilson FA, Wang Y. Recent findings on the prevalence of E-cigarette use among adults in the U.S. Am. J. Prev. Med. 2017; 52: 385–90.
6. Fulton E, Gokal K, Griffiths S, Wild S. More than half of adolescent E-cigarette users had never smoked a cigarette: findings from a study of school children in the UK. Public Health 2018; 161: 33–5.
7. McCabe SE, West BT, McCabe VV. Associations between early onset of E-cigarette use and cigarette smoking and other substance use among US adolescents: a national study. Nicotine Tob. Res. 2018; 20: 923–30.
8. Primack BA, Soneji S, Stoolmiller M, Fine MJ, Sargent JD. Progression to traditional cigarette smoking after electronic cigarette use among US adolescents and young adults. JAMA Pediatr. 2015; 169: 1018–23.
9. Wills TA, Sargent JD, Gibbons FX, Pagano I, Schweitzer R. E-cigarette use is differentially related to smoking onset among lower risk adolescents. Tob. Control 2016; 26: 534–9.
10. Leventhal AM, Strong DR, Kirkpatrick MG, Unger JB, Sussman S, Riggs NR, Stone MD, Khoddam R, Samet JM, Audrain-McGovern J. Association of electronic cigarette use with initiation of combustible tobacco product smoking in early adolescence. JAMA 2015; 314: 700–7.
11. VaporFi. Top 10 best selling e-juices in Australia. [Accessed 11 July 2018.] Available from URL: https://www.vaporfi.com.au/blog/top-10-best-selling-e-juices-in-australia/
12. Wang L, Zhan Y, Li Q, Zeng DD, Leischow SJ, Okamoto J. An examination of electronic cigarette content on social media: analysis of E-cigarette flavor content on Reddit. Int. J. Environ. Res. Public Health 2015; 12: 14916–35.
13. Pepper JK, Ribisl KM, Brewer NT. Adolescents' interest in trying flavoured e-cigarettes. Tob. Control 2016; 25: ii62–6.
14. Rowell TR, Reeber SL, Lee SL, Harris RA, Nethery RC, Herring AH, Glish GL, Tarran R. Flavored e-cigarette liquids reduce proliferation and viability in the CALU3 airway epithelial cell line. Am. J. Physiol. Lung Cell. Mol. Physiol. 2017; 313: L52–66.
15. Cervellati F, Muresan XM, Sticozzi C, Gambari R, Montagner G, Forman HJ, Torricelli C, Maioli E, Valacchi G. Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. Toxicol. In Vitro 2014; 28: 999–1005.
16. Scheffler S, Dieken H, Krischenowski O, Forster C, Branscheid D, Aufderheide M. Evaluation of E-cigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells. Int. J. Environ. Res. Public Health 2015; 12: 3915–25.
17. Schweitzer KS, Chen SX, Law S, Van Demark MJ, Poirier C, Justice MJ, Hubbard WC, Kim ES, Lai X, Wang M et al. Endothelial disruptive pro-inflammatory effects of nicotine and e-cigarette vapor exposures. Am. J. Physiol. Lung Cell Mol. Physiol. 2015; 309: L175–87.
18. Lim HB, Kim SH. Inhalation of e-cigarette cartridge solution aggravates allergen-induced airway inflammation and hyper-responsiveness in mice. Toxicol. Res. 2014; 30: 13–8.
19. Larcombe AN, Janka MA, Mullins BJ, Berry LJ, Bredin A, Franklin PJ. The effects of electronic cigarette aerosol exposure on inflammation and lung function in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2017; 313: L67–79.
20. Wu Q, Jiang D, Minor M, Chu HW. Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells. PLoS One 2014; 9: e108342.
21. Sussan TE, Gajghate S, Thimmulappa RK, Ma J, Kim JH, Sudini K, Consolini N, Cormier SA, Lomnicki S, Hasan F et al. Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defences in a mouse model. PLoS One 2015; 10: e0116861.
22. King P. Haemophilus influenzae and the lung (Haemophilus and the lung). Clin. Transl. Med. 2012; 1: 10.
23. Ween M, Ahern J, Carroll A, Hodge G, Pizzutto S, Jersmann H, Reynolds P, Hodge S. A small volume technique to examine and compare alveolar macrophage phagocytosis of apoptotic cells and non typeable Haemophilus influenzae (NTHi). J. Immunol. Methods 2016; 429: 7–14.
24. Hodge S, Reynolds PN. Low-dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophages in chronic obstructive pulmonary disease subjects. Respirology 2012; 17: 802–7.
25. Hodge S, Hodge G, Holmes M, Reynolds PN. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur. Respir. J. 2005; 25: 447–54.
26. Tran HB, Barnawi J, Ween M, Hamon R, Roscioli E, Hodge G, Reynolds PN, Pitson SM, Davies LT, Haberberger R et al. Cigarette smoke inhibits efferocytosis via deregulation of sphingosine kinase signaling: reversal with exogenous S1P and the S1P analogue FTY720. J. Leukoc. Biol. 2016; 100: 195–202.
27. Hodge S, Dean M, Hodge G, Holmes M, Reynolds PN. Decreased efferocytosis and mannose binding lectin in the airway in bronchiolitis obliterans syndrome. J. Heart Lung Transplant. 2011; 30: 589–95.
28. Behar RZ, Hua M, Talbot P. Puffing topography and nicotine intake of electronic cigarette users. PLoS One 2015; 10: e0117222.
29. Hodge S, Tran HB, Hamon R, Roscioli E, Hodge G, Jersmann H, Ween M, Reynolds PN, Yeung A, Treiberg J et al. Nonantibiotic macrolides restore airway macrophage phagocytic function with potential anti-inflammatory effects in chronic lung diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 2017; 312: L678–L87.
30. Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds PN. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 2007; 37: 748–55.
31. Sherwood CL, Boitano S. Airway epithelial cell exposure to distinct e-cigarette liquid flavorings reveals toxicity thresholds and activation of CFTR by the chocolate flavoring 2,5-dimethypyrazine. Respir. Res. 2016; 17: 57.
32. Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod. Toxicol. 2012; 34: 529–37.
33. McGrath-Morrow SA, Hayashi M, Aherrera A, Lopez A, Malinina A, Collaco JM, Neptune E, Klein JD, Winickoff JP, Breysse P et al. The effects of electronic cigarette emissions on systemic cotinine levels, weight and postnatal lung growth in neonatal mice. PLoS One 2015; 10: e0118344.
34. Sancilio S, Gallorini M, Cataldi A, di Giacomo V. Cytotoxicity and apoptosis induction by e-cigarette fluids in human gingival fibroblasts. Clin. Oral Investig. 2016; 20: 477–83.
35. Welz C, Canis M, Schwenk-Zieger S, Becker S, Stucke V, Ihler F, Baumeister P. Cytotoxic and genotoxic effects of electronic cigarette liquids on human mucosal tissue cultures of the oropharynx. J. Environ. Pathol. Toxicol. Oncol. 2016; 35: 343–54.
36. El Golli N, Rahali D, Jrad-Lamine A, Dallagi Y, Jallouli M, Bdiri Y, Ba N, Lebret M, Rosa JP, El May M et al. Impact of electronic-cigarette refill liquid on rat testis. Toxicol. Mech. Methods 2016; 26: 427–34.
37. Modi P, Yadava V, Sreedhar R, Khasawaneh F, Balk RA. A case of flavor-induced lung disease. South. Med. J. 2008; 101: 541–2.
38. Halldin CN, Suarthana E, Fedan KB, Lo YC, Turabelidze G, Kreiss K. Increased respiratory disease mortality at a microwave popcorn production facility with worker risk of bronchiolitis obliterans. PLoS One 2013; 8: e57935.
39. Putzhammer R, Doppler C, Jakschitz T, Heinz K, Forste J, Danzl K, Messner B, Bernhard D. Vapours of US and EU market leader electronic cigarette brands and liquids are cytotoxic for human vascular endothelial cells. PLoS One 2016; 11: e0157337.
40. Romagna G, Allifranchini E, Bocchietto E, Todeschi S, Esposito M, Farsalinos KE. Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract. Inhal. Toxicol. 2013; 25: 354–61.
41. Yu V, Rahimy M, Korrapati A, Xuan Y, Zou AE, Krishnan AR, Tsui T, Aguilera JA, Advani S, Crotty Alexander LE et al. Electronic cigarettes induce DNA strand breaks and cell death independently of nicotine in cell lines. Oral Oncol. 2016; 52: 58–65.
42. Leslie LJ, Vasanthi Bathrinarayanan P, Jackson P, Mabiala Ma Muanda JA, Pallett R, CJP S, Marshall LJ. A comparative study of electronic cigarette vapor extracts on airway-related cell lines in vitro. Inhal. Toxicol. 2017; 29: 126–36.
43. Lerner CA, Sundar IK, Yao H, Gerloff J, Ossip DJ, McIntosh S, Robinson R, Rahman I. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One 2015; 10: e0116732.
44. Fetterman JL, Weisbrod RM, Feng B, Bastin R, Tuttle ST, Holbrook M, Baker G, Robertson RM, Conklin DJ, Bhatnagar A et al. Flavorings in tobacco products induce endothelial cell dysfunction. Arterioscler. Thromb. Vasc. Biol. 2018; 38: 1607–15.
45. Muthumalage T, Prinz M, Ansah KO, Gerloff J, Sundar IK, Rahman I. Inflammatory and oxidative responses induced by exposure to commonly used e-cigarette flavoring chemicals and flavored e-liquids without nicotine. Front. Physiol. 2017; 8: 1130.
46. Kosmider L, Sobczak A, Prokopowicz A, Kurek J, Zaciera M, Knysak J, Smith D, Goniewicz ML. Cherry-flavoured electronic cigarettes expose users to the inhalation irritant, benzaldehyde. Thorax 2016; 71: 376–7.
47. Rouabhia M, Park HJ, Semlali A, Zakrzewski A, Chmielewski W, Chakir J. E-cigarette vapor induces an apoptotic response in human gingival epithelial cells through the caspase-3 pathway. J. Cell. Physiol. 2017; 232: 1539–47.
48. Makris D, Vrekoussis T, Izoldi M, Alexandra K, Katerina D, Dimitris T, Michalis A, Tzortzaki E, Siafakas NM, Tzanakis N. Increased apoptosis of neutrophils in induced sputum of COPD patients. Respir. Med. 2009; 103: 1130–5.
49. Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 2006; 129: 1673–82.
50. Hodge S, Hodge G, Brozyna S, Jersmann H, Holmes M, Reynolds PN. Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages. Eur. Respir. J. 2006; 28: 486–95.
51. Kirkham PA, Spooner G, Rahman I, Rossi AG. Macrophage phagocytosis of apoptotic neutrophils is compromised by matrix proteins modified by cigarette smoke and lipid peroxidation products. Biochem. Biophys. Res. Commun. 2004; 318: 32–7.
52. Hodge S, Hodge G, Scicchitano R, Reynolds PN, Holmes M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol. Cell Biol. 2003; 81: 289–96.
53. Noda N, Matsumoto K, Fukuyama S, Asai Y, Kitajima H, Seki N, Matsunaga Y, Kan OK, Moriwaki A, Morimoto K et al. Cigarette smoke impairs phagocytosis of apoptotic neutrophils by alveolar macrophages via inhibition of the histone deacetylase/Rac/CD9 pathways. Int. Immunol. 2013; 25: 643–50.
54. Clapp PW, Pawlak EA, Lackey JT, Keating JE, Reeber SL, Glish GL, Jaspers I. Flavored e-cigarette liquids and cinnamaldehyde impair respiratory innate immune cell function. Am. J. Physiol. Lung Cell. Mol. Physiol. 2017; 313: L278–L92.
55. Hwang JH, Lyes M, Sladewski K, Enany S, McEachern E, Mathew DP, Das S, Moshensky A, Bapat S, Pride DT et al. Electronic cigarette inhalation alters innate immunity and airway cytokines while increasing the virulence of colonizing bacteria. J. Mol. Med. 2016; 94: 667–79.
56. Heguy A, O'Connor TP, Luettich K, Worgall S, Cieciuch A, Harvey BG, Hackett NR, Crystal RG. Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. J. Mol. Med. 2006; 84: 318–28.
57. Guzik K, Skret J, Smagur J, Bzowska M, Gajkowska B, Scott DA, Potempa JS. Cigarette smoke-exposed neutrophils die unconventionally but are rapidly phagocytosed by macrophages. Cell Death Dis. 2011; 2: e131.
58. Pons AR, Noguera A, Blanquer D, Sauleda J, Pons J, Agusti AG. Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD. Eur. Respir. J. 2005; 25: 647–52.
59. Rankin GD, Wingfors H, Uski O, Hedman L, Ekstrand-Hammarstrom B, Bosson J, Lundback M. The toxic potential of a fourth-generation E-cigarette on human lung cell lines and tissue explants. J. Appl. Toxicol. 2019; 39: 1143–54.
60. Gerloff J, Sundar IK, Freter R, Sekera ER, Friedman AE, Robinson R, Pagano T, Rahman I. Inflammatory response and barrier dysfunction by different e-cigarette flavoring chemicals identified by gas chromatography-mass spectrometry in e-liquids and e-vapors on human lung epithelial cells and fibroblasts. Appl. in vitro Toxicol. 2017; 3: 28–40.
61. Lerner CA, Rutagarama P, Ahmad T, Sundar IK, Elder A, Rahman I. Electronic cigarette aerosols and copper nanoparticles induce mitochondrial stress and promote DNA fragmentation in lung fibroblasts. Biochem. Biophys. Res. Commun. 2016; 477: 620–5.
62. Garcia-Arcos I, Geraghty P, Baumlin N, Campos M, Dabo AJ, Jundi B, Cummins N, Eden E, Grosche A, Salathe M et al. Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner. Thorax 2016; 71: 1119–29.
63. van der Vaart H, Postma DS, Timens W, ten Hacken NH. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 2004; 59: 713–21.
64. Glynos C, Bibli SI, Katsaounou P, Pavlidou A, Magkou C, Karavana V, Topouzis S, Kalomenidis I, Zakynthinos S, Papapetropoulos A. Comparison of the effects of e-cigarette vapor with cigarette smoke on lung function and inflammation in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2018; 315: L662–L72.
65. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011; 378: 1015–26.
66. Aszyk J, Kubica P, Wozniak MK, Namiesnik J, Wasik A, Kot-Wasik A. Evaluation of flavour profiles in e-cigarette refill solutions using gas chromatography-tandem mass spectrometry. J. Chromatogr. A 2018; 1547: 86–98.
67. Lisko JG, Tran H, Stanfill SB, Blount BC, Watson CH. Chemical composition and evaluation of nicotine, tobacco alkaloids, pH, and selected flavors in E-cigarette cartridges and refill solutions. Nicotine Tob. Res. 2015; 17: 1270–8.
68. Tierney PA, Karpinski CD, Brown JE, Luo W, Pankow JF. Flavour chemicals in electronic cigarette fluids. Tob. Control 2016; 25: e10–5.
69. Erythropel HC, Jabba SV, DeWinter TM, Mendizabal M, Anastas PT, Jordt SE, Zimmerman JB. Formation of flavorant-propylene glycol adducts with novel toxicological properties in chemically unstable E-cigarette liquids. Nicotine Tob. Res. 2019; 21: 1248–58.